Literature DB >> 10498238

Folate levels in psychiatric outpatients.

A Herrán1, M T García-Unzueta, J A Amado, J J López-Cordovilla, J F Díez-Manrique, J L Vázquez-Barquero.   

Abstract

This study examines folate in psychiatric outpatients. Fifty-three outpatients with schizophrenia and 24 outpatients with depressive disorder assessed with the Schedules for Clinical Assessment in Neuropsychiatry interview are included. Patients with schizophrenia had lower serum folate levels than age- and sex-matched controls, while red cell folate levels did not differ. Serum folate levels showed a negative correlation with the Clinical Global Impression, disorganized dimension, and total Positive and Negative Syndrome Scale score. Patients with depressive disorder had lower serum folate levels than healthy controls, but showed no differences in red cell folate levels. Only two patients with schizophrenia had red cell folate levels below the normal range.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10498238     DOI: 10.1046/j.1440-1819.1999.00572.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  8 in total

1.  Epigenetics of programmed obesity: alteration in IUGR rat hepatic IGF1 mRNA expression and histone structure in rapid vs. delayed postnatal catch-up growth.

Authors:  Darran N Tosh; Qi Fu; Christopher W Callaway; Robert A McKnight; Isabella C McMillen; Michael G Ross; Robert H Lane; Mina Desai
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-09-02       Impact factor: 4.052

2.  Genetic variation throughout the folate metabolic pathway influences negative symptom severity in schizophrenia.

Authors:  Joshua L Roffman; David G Brohawn; Adam Z Nitenson; Eric A Macklin; Jordan W Smoller; Donald C Goff
Journal:  Schizophr Bull       Date:  2011-10-20       Impact factor: 9.306

3.  Randomized multicenter investigation of folate plus vitamin B12 supplementation in schizophrenia.

Authors:  Joshua L Roffman; J Steven Lamberti; Eric Achtyes; Eric A Macklin; Gail C Galendez; Lisa H Raeke; Noah J Silverstein; Jordan W Smoller; Michele Hill; Donald C Goff
Journal:  JAMA Psychiatry       Date:  2013-05       Impact factor: 21.596

4.  Folate and vitamin B12 status in schizophrenic patients.

Authors:  Ahmad Saedisomeolia; Mahmoud Djalali; Ali Malekshahi Moghadam; Ozra Ramezankhani; Laya Najmi
Journal:  J Res Med Sci       Date:  2011-03       Impact factor: 1.852

5.  Biochemical, physiological and clinical effects of l-methylfolate in schizophrenia: a randomized controlled trial.

Authors:  J L Roffman; L J Petruzzi; A S Tanner; H E Brown; H Eryilmaz; N F Ho; M Giegold; N J Silverstein; T Bottiglieri; D S Manoach; J W Smoller; D C Henderson; D C Goff
Journal:  Mol Psychiatry       Date:  2017-03-14       Impact factor: 15.992

6.  Association between increased plasma levels of homocysteine and depression observed in individuals with primary lactose malabsorption.

Authors:  Dietmar Enko; Andreas Meinitzer; Wolfgang Brandmayr; Gabriele Halwachs-Baumann; Wolfgang J Schnedl; Gernot Kriegshäuser
Journal:  PLoS One       Date:  2018-08-23       Impact factor: 3.240

7.  Genetic and environmental factors in complex neurodevelopmental disorders.

Authors:  K M J van Loo; G J M Martens
Journal:  Curr Genomics       Date:  2007-11       Impact factor: 2.236

8.  Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and age at onset of schizophrenia: no consistent evidence for an association in the Nordic population.

Authors:  Peter Saetre; Jakob Grove; Anders D Børglum; Ole Mors; Thomas Werge; Ole A Andreassen; Maria Vares; Ingrid Agartz; Lars Terenius; Erik G Jönsson
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-10-17       Impact factor: 3.568

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.